291 related articles for article (PubMed ID: 34058315)
1. Berberine for bone regeneration: Therapeutic potential and molecular mechanisms.
Zhang Y; Ma J; Zhang W
J Ethnopharmacol; 2021 Sep; 277():114249. PubMed ID: 34058315
[TBL] [Abstract][Full Text] [Related]
2. Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies.
Yang Y; Vong CT; Zeng S; Gao C; Chen Z; Fu C; Wang S; Zou L; Wang A; Wang Y
J Ethnopharmacol; 2021 Mar; 268():113573. PubMed ID: 33181286
[TBL] [Abstract][Full Text] [Related]
3. Jatrorrhizine: a review of its pharmacological effects.
Rolle J; Asante DO; Kok-Fong LL; Boucetta H; Seidu TA; Tai LLK; Alolga RN
J Pharm Pharmacol; 2021 Apr; 73(6):709-719. PubMed ID: 33822109
[TBL] [Abstract][Full Text] [Related]
4. [Investigation on pattern and methods of quality control for Chinese materia medica based on dao-di herbs and bioassay - bioassay for Coptis chinensis].
Yan D; Xiao XH
Yao Xue Xue Bao; 2011 May; 46(5):568-72. PubMed ID: 21800546
[TBL] [Abstract][Full Text] [Related]
5. [Research development of Coptis chinensis].
Xu JT; Wang LQ; Xu B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):704-7. PubMed ID: 15663237
[TBL] [Abstract][Full Text] [Related]
6. [Advances of the mechanism study on berberine in the control of blood glucose and lipid as well as metabolism disorders].
Shen N; Li CN; Huan Y; Shen ZF
Yao Xue Xue Bao; 2010 Jun; 45(6):699-704. PubMed ID: 20939176
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in chemistry and bioactivity of Sargentodoxa cuneata.
Zhang W; Sun C; Zhou S; Zhao W; Wang L; Sheng L; Yi J; Liu T; Yan J; Ma X; Fang B
J Ethnopharmacol; 2021 Apr; 270():113840. PubMed ID: 33460761
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis.
Wang K; Yin J; Chen J; Ma J; Si H; Xia D
Phytomedicine; 2024 Jun; 128():155258. PubMed ID: 38522318
[TBL] [Abstract][Full Text] [Related]
9. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.
Tang J; Feng Y; Tsao S; Wang N; Curtain R; Wang Y
J Ethnopharmacol; 2009 Oct; 126(1):5-17. PubMed ID: 19686830
[TBL] [Abstract][Full Text] [Related]
10. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological effects of berberine and its derivatives: a patent update.
Jin Y; Khadka DB; Cho WJ
Expert Opin Ther Pat; 2016; 26(2):229-43. PubMed ID: 26610159
[TBL] [Abstract][Full Text] [Related]
12. Berberine Derivatives with Different Pharmacological Activities via Structural Modifications.
Xiao D; Liu Z; Zhang S; Zhou M; He F; Zou M; Peng J; Xie X; Liu Y; Peng D
Mini Rev Med Chem; 2018; 18(17):1424-1441. PubMed ID: 28325147
[TBL] [Abstract][Full Text] [Related]
13. Regulation of bone homeostasis by traditional Chinese medicine active scaffolds and enhancement for the osteoporosis bone regeneration.
Wang X; Tang P; Yang K; Guo S; Tang Y; Zhang H; Wang Q
J Ethnopharmacol; 2024 Jul; 329():118141. PubMed ID: 38570149
[TBL] [Abstract][Full Text] [Related]
14. Berberis Vulgaris and Berberine: An Update Review.
Imenshahidi M; Hosseinzadeh H
Phytother Res; 2016 Nov; 30(11):1745-1764. PubMed ID: 27528198
[TBL] [Abstract][Full Text] [Related]
15. Biological properties and clinical applications of berberine.
Song D; Hao J; Fan D
Front Med; 2020 Oct; 14(5):564-582. PubMed ID: 32335802
[TBL] [Abstract][Full Text] [Related]
16. Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San.
Chin LW; Cheng YW; Lin SS; Lai YY; Lin LY; Chou MY; Chou MC; Yang CC
Arch Virol; 2010 Dec; 155(12):1933-41. PubMed ID: 20686799
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine.
Imanshahidi M; Hosseinzadeh H
Phytother Res; 2008 Aug; 22(8):999-1012. PubMed ID: 18618524
[TBL] [Abstract][Full Text] [Related]
18. Angelica sinensis in China-A review of botanical profile, ethnopharmacology, phytochemistry and chemical analysis.
Wei WL; Zeng R; Gu CM; Qu Y; Huang LF
J Ethnopharmacol; 2016 Aug; 190():116-41. PubMed ID: 27211015
[TBL] [Abstract][Full Text] [Related]
19. [Advance on study in anti-atherosclerosis mechanism of berberine].
Wu M; Wang J
Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(18):2013-6. PubMed ID: 19160773
[TBL] [Abstract][Full Text] [Related]
20. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives.
Wang N; Tan HY; Li L; Yuen MF; Feng Y
J Ethnopharmacol; 2015 Dec; 176():35-48. PubMed ID: 26494507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
